@misc{indiciae51b017cfab54,
  title = {A targeted, low-throughput compound screen in a Drosophila model of Neurofibromatosis Type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD).},
  author = {Dyson, A. and Ryan, M. and Garg, S. and Evans, D. G. and Baines, R.},
  year = {2022},
  doi = {10.1101/2022.11.11.516139},
  url = {https://www.biorxiv.org/content/10.1101/2022.11.11.516139v1},
  note = {Source identifier: 10.1101/2022.11.11.516139}
}